Literature DB >> 10688614

Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts.

A Oriente1, N S Fedarko, S E Pacocha, S K Huang, L M Lichtenstein, D M Essayan.   

Abstract

Interleukin (IL)-13 has been implicated in the pathogenesis of various diseases characterized by fibrosis. We describe the effects of IL-13 on collagen homeostasis from normal (NF) and keloid (KF) fibroblasts and compare these effects with those of IL-4 and transforming growth factor (TGF)-beta(1). Total collagen generation was up-regulated in NF after 48 h of stimulation by IL-13; in KF, IL-13 stimulated a more rapid collagen response. The kinetics and magnitude of collagen generation induced by IL-13 were equivalent to those induced by similar concentrations of IL-4 and TGF-beta(1). Collagen type I production paralleled total collagen generation from both NF and KF; however, IL-4-induced collagen type I and total collagen production from KF was more transient than that induced by either IL-13 or TGF-beta(1). Procollagen 1alpha1 gene expression was induced in KF by stimulation with IL-13 for 24 h. Moreover, IL-13 was unique among these three cytokines in its ability to induce gene expression for procollagen 3alpha1. Finally, IL-13 inhibited IL-1beta-induced matrix metalloproteinase (MMP)-1 and MMP-3 production and enhanced tissue inhibitor of metalloproteinase (TIMP)-1 generation from NF; although similar effects were observed with IL-4, TGF-beta(1) transiently enhanced MMP-1 and MMP-3 generation without effecting TIMP-1. In KF, IL-13 and IL-4 inhibited MMP-3, whereas TGF-beta(1) enhanced MMP-3; TIMP-1 was unaffected by any of the three cytokines. These data demonstrate both the profibrotic effects of IL-13 on collagen homeostasis and the potential differential regulation of collagen homeostasis in fibroblast subtypes by IL-13.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688614

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  63 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

Authors:  Bethany B Moore; Jill E Kolodsick; Victor J Thannickal; Kenneth Cooke; Thomas A Moore; Cory Hogaboam; Carol A Wilke; Galen B Toews
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

Review 4.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

Review 5.  The role of the acquired immune response in systemic sclerosis.

Authors:  Carlo Chizzolini; Francesco Boin
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

6.  A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis.

Authors:  W Kenneth Ward
Journal:  J Diabetes Sci Technol       Date:  2008-09

Review 7.  Peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Rekha Vij; Imre Noth
Journal:  Transl Res       Date:  2012-02-02       Impact factor: 7.012

Review 8.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

Review 9.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

10.  A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.

Authors:  Yenny Djuardi; Erliyani Sartono; Heri Wibowo; Taniawati Supali; Maria Yazdanbakhsh
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.